登录 注册 会员服务 联系我们

Lung cancer as a paradigm for precision oncology in solid tumours

  • Published:2017-07-20 Issue:2 Volume:471 Page:221-233
  • ISSN:0945-6317
  • Container-title:Virchows Archiv
  • language:en
  • Short-container-title:Virchows Arch

Author:

Schallenberg Simon,Merkelbach-Bruse Sabine,Buettner Reinhard

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Reference132 articles.

1. Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, Amatu A, Bencardino K, Palmeri L, Sartore-Bianchi A, Vanzulli A, Cresta S, Damian S, Duca M, Ardini E, Li G, Christiansen J, Kowalski K, Johnson A, Patel R, Luo D, Chow-Maneval E, Hornby Z, Multani PS, Shaw AT, De Braud FG (2017) Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1). Cancer Discov. doi: 10.1158/2159-8290.CD-16-1237

2. Bir F, Çeliker D, Evyapan BF, Yaren A, Edirne T (2016) New immunohistochemical markers in the differential diagnosis of nonsmall cell lung carcinoma. Turk J Med Sci 46(6):1854–1861. doi: 10.3906/sag-1501-68

3. Wolf J (2017) Network Genomic Medicine. http://www.ngm-cancer.com/ . Accessed 10 April 2017

4. Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, Thunnissen E, Ladanyi M, College of American Pathologists International Association for the Study of Lung Cancer and Association for Molecular Pathology (2013) Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Mol Diagn 15(4):415–453. doi: 10.1016/j.jmoldx.2013.03.001

5. Novello S, Barlesi F, Califano R, Cufer T, Ekman S, Levra MG, Kerr K, Popat S, Reck M, Senan S, Simo GV, Vansteenkiste J, Peters S, Guidelines Committee ESMO (2016) Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v1–v27

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Krebsdiagnostik;Molekularbiologie menschlicher Krebserkrankungen;2024

2. Lungenkrebs;Molekularbiologie menschlicher Krebserkrankungen;2024

3. Cancer Diagnostics;Molecular Biology of Human Cancers;2023

4. Lung Cancer;Molecular Biology of Human Cancers;2023

5. Comparison of an oncology clinical decision-support system’s recommendations with actual treatment decisions;Journal of the American Medical Informatics Association;2021-01-31
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3